COL12A1 and infantile convulsions and choreoathetosis: The median overall survival time was significantly shorter in iCCA patients with COL12A1-high expression than iCCA patient with COL12A1-low expression from TCGA, OEP001105, E-MTAB-6389 and LVC1202 cohorts (18.55 (10.16–29.54) months vs. 53.45 (29.62–75.53) months, p = 0.014, Fig. 3E).